These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
864 related articles for article (PubMed ID: 12623513)
21. [Determinant factors in the acute functional deterioration caused by the inhibition of the conversion enzyme in reno-vascular arterial hypertension]. Ribstein J; Mourad G; Mimran A Arch Mal Coeur Vaiss; 1987 Jun; 80(6):866-9. PubMed ID: 3116987 [TBL] [Abstract][Full Text] [Related]
22. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension. Valvo E; Gammaro L; Bedogna V; Tonon M; Giorgetti P; Pica B; Antonini P; Tessitore N; Oldrizzi L; Rugiu C Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196 [TBL] [Abstract][Full Text] [Related]
24. PGl2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency. Fujita T; Fuke Y; Satomura A; Hidaka M; Ohsawa I; Endo M; Komatsu K; Ohi H Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):223-7. PubMed ID: 11728176 [TBL] [Abstract][Full Text] [Related]
25. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children]. Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899 [TBL] [Abstract][Full Text] [Related]
26. Contrasting effects of acute angiotensin converting enzyme inhibitors and calcium antagonists in transplant renal artery stenosis. Mourad G; Ribstein J; Argiles A; Mimran A; Mion C Nephrol Dial Transplant; 1989; 4(1):66-70. PubMed ID: 2494601 [TBL] [Abstract][Full Text] [Related]
27. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension. Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742 [TBL] [Abstract][Full Text] [Related]
28. The effects of nifedipine and captopril on renal function in patients with essential hypertension: comparison with sodium nitroprusside. Hara A; Matsunaga M; Ogawa K; Pak CH; Kawai C; Nakamura T J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S164-6. PubMed ID: 2455123 [TBL] [Abstract][Full Text] [Related]
29. Does captopril reduce renal function in renovascular disease by postglomerular vasodilatation? Schwietzer G; Laass C; Kampf D; Bähr V; Schultze G; Molzahn M; Distler A J Hypertens Suppl; 1985 Nov; 3(2):S139-41. PubMed ID: 3910770 [TBL] [Abstract][Full Text] [Related]
30. [Arterial hypertension in senile pyelonephritis: the renal hemodynamics]. Gordeev AV; Savitskiĭ SN; Malyshev IuM; Sura VV Ter Arkh; 1990; 62(11):79-82. PubMed ID: 2094998 [TBL] [Abstract][Full Text] [Related]
31. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading. Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440 [TBL] [Abstract][Full Text] [Related]
32. Acute renal effects of captopril in patients with congestive heart failure. Ribstein J; Mimran A J Clin Hypertens; 1986 Sep; 2(3):238-44. PubMed ID: 3023554 [TBL] [Abstract][Full Text] [Related]
33. Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: a randomized, double-blind, controlled trial. Ottesen LH; Aagaard NK; Kiszka-Kanowitz M; Rehling M; Henriksen JH; Pedersen EB; Flyvbjerg A; Bendtsen F Hepatology; 2001 Sep; 34(3):471-7. PubMed ID: 11526531 [TBL] [Abstract][Full Text] [Related]
34. Combined actions of isradipine and captopril on renal function in hypertension. Krusell LR; Sihm I; Jespersen LT; Thomsen K; Pedersen EB; Pedersen OL J Hum Hypertens; 1992 Oct; 6(5):401-7. PubMed ID: 1464898 [TBL] [Abstract][Full Text] [Related]
35. [Effect of water immersion on levels of atrial natriuretic peptide in patients with chronic renal failure]. Zukowska-Szczechowska E; Kokot F; Grzeszczak W; Wiecek A Pol Tyg Lek; 1989 Sep 4-25; 44(36-39):839-42. PubMed ID: 2535018 [TBL] [Abstract][Full Text] [Related]
36. Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease. Dhaun N; Ferro CJ; Davenport AP; Haynes WG; Goddard J; Webb DJ Nephrol Dial Transplant; 2007 Nov; 22(11):3228-34. PubMed ID: 17556408 [TBL] [Abstract][Full Text] [Related]
37. Renal haemodynamics and function in weanling rats treated with enalapril from birth. Guron G Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949 [TBL] [Abstract][Full Text] [Related]
38. [Arterial hypertension in patients on chronic hemodialysis]. Zogović J; Mladenović Lj Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857 [TBL] [Abstract][Full Text] [Related]
39. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function]. Osterziel KJ; Nagel F; Dietz R Z Kardiol; 1994; 83 Suppl 4():81-7. PubMed ID: 7856286 [TBL] [Abstract][Full Text] [Related]
40. Impaired renal haemodynamic response to L-arginine in essential hypertension: role of buffering anion and tubuloglomerular feedback. Biggi A; Carra N; Cabassi A; Barilli AL; Musiari L; Iori M; De Iaco G; Azzarone M; Novarini A; Montanari A J Hypertens; 2007 Mar; 25(3):679-88. PubMed ID: 17278985 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]